FDC Ltd Q1 FY27 Revenue Up 3% to ₹668 Cr, US Business Surges

FDC Limited announced its unaudited financial results for Q1 FY27, reporting a 3.0% year-on-year increase in consolidated revenue from operations to ₹668 crores. EBITDA grew by 1.9% to ₹143 crores, while Profit Before Tax (PBT) and Profit After Tax (PAT) saw increases of 9.4% and 9.2% respectively. Earnings Per Share (EPS) rose to ₹8.14 from ₹7.45 in the prior year. The growth was primarily driven by strong performance in International Formulations, especially the US business, which surged 118.4%. Domestic Formulations and APIs experienced a slight decline. The company also received US FDA approval for Cefixime for Oral Suspension.